[1]
|
张明鑫. 消化道早癌如何防治[J]. 家庭医药. 就医选药, 2021(11): 32-33.
|
[2]
|
Muñoz-Colmenero, A., Fernán-dez-Suárez, A., Fatela-Cantillo, D., et al. (2015) Plasma Tumor M2-Pyruvate Kinase Levels in Different Cancer Types. Anticancer Research, 35, 4271-4276.
|
[3]
|
Christofk, H.R., Heiden, M., Harris, M.H., et al. (2008) The M2 Splice Iso-form of Pyruvate Kinase Is Important for Cancer Metabolism and Tumour Growth. Nature, 452, 230-233. https://doi.org/10.1038/nature06734
|
[4]
|
Munoz-Colmenero, A., Fernandez-Suarez, A., Fatela-Cantillo, D., et al. (2015) Plasma Tumor M2-Pyruvate Kinase Levels in Different Cancer Types. Anticancer Research: International Jour-nal of Cancer Research and Treatment, 35, 4271-4276.
|
[5]
|
Dong, G.C., Mao, Q.X., Xia, W.J., et al. (2016) PKM2 and Cancer: The Function of PKM2 beyond Glycolysis. Oncology Letters, 11, 1980-1986. https://doi.org/10.3892/ol.2016.4168
|
[6]
|
Rihan, M., Nalla, L.V., Dharavath, A., et al. (2019) Pyruvate Kinase M2: A Metabolic Bug in Re-Wiring the Tumor Microenvironment. Cancer Microenvironment, 12, 149-167. https://doi.org/10.1007/s12307-019-00226-0
|
[7]
|
高洋, 孙昭, 白春梅. 丙酮酸激酶M2在胃癌中的作用[J]. 协和医学杂志, 2021, 12(2): 227-231.
|
[8]
|
Chen, M., David, C.J. and Manley, J.L. (2012) Concentration-Dependent Control of Pyruvate Kinase M Mutually Exclusive Splicing by hnRNP Proteins. Nature Structural & Molecular Biology, 19, 346-354.
https://doi.org/10.1038/nsmb.2219
|
[9]
|
David, C.J., Chen, M., Assanah, M., et al. (2010) HnRNP Proteins Con-trolled by c-Myc Deregulate Pyruvate Kinase mRNA Splicing in Cancer. Nature, 463, 364-368. https://doi.org/10.1038/nature08697
|
[10]
|
孙倩. M2型丙酮酸激酶(PKM2)在肿瘤代谢和发生中的作用[J]. 基础医学与临床, 2012, 32(5): 462-467.
|
[11]
|
Novotný, I., Dite, P., Dastych, M., et al. (2008) Tumor Marker M2-Pyruvate-Kinase in Differential Diagnosis of Chronic Pancreatitis and Pancreatic Cancer. Hepato-Gastroenterology, 55, 1475-1477.
|
[12]
|
Landt, S., Jeschke, S., Koeninger, A., et al. (2010) Tumor-Specific Correlation of Tumor M2 Py-ruvate Kinase in Pre-Invasive, Invasive and Recurrent Cervical Cancer. Anticancer Research, 30, 375.
|
[13]
|
Levic, K., Bulut, O., Hesselfeldt, P., et al. (2013) The Outcome of Rectal Cancer after Early Salvage TME Following TEM Com-pared with Primary TME: A Case-Matched Study. Techniques in Coloproctology, 17, 397-403.
https://doi.org/10.1007/s10151-012-0950-2
|
[14]
|
杨刚, 唐丽娟. 血清TuM2-PK、CEA、CA19-9和CA72-4对结肠癌的筛查价值[J]. 检验医学与临床, 2017, 14(1): 35-36+39.
|
[15]
|
杜宇, 阳振曦, 苏建荣. 胶体金法粪便检测TU M2PK在结直肠癌诊断中的价值[J]. 空军医学杂志, 2019, 35(3): 229-232.
|
[16]
|
张丹. 肿瘤M2型丙酮酸激酶检测在结肠癌诊断中的临床价值[J]. 中国卫生标准管理, 2021, 12(6): 95-98.
|
[17]
|
王俊伟, 金心富, 卢凯. 腹腔镜切除术配合FOLFOX4新辅助化疗对直肠癌患者血清FAS、Tu M2-PK及T细胞亚群的影响[J]. 临床和实验医学杂志, 2019, 18(9): 981-985.
|
[18]
|
Li, S., Ji, X., Wang, R., et al. (2019) Follicle-Stimulating Hormone Promoted Py-ruvate Kinase Isozyme Type M2-Induced Glycolysis and Proliferation of Ovarian Cancer Cells. Archives of Gynecology and Obstetrics, 299, 1443-1451.
https://doi.org/10.1007/s00404-019-05100-4
|
[19]
|
Zhou, Z.F., Li, M., Zhang, L., et al. (2018) Oncogenic Ki-nase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-Like Cells. Cancer Research, 78, 2248-2261.
https://doi.org/10.1158/0008-5472.CAN-17-2726
|
[20]
|
Rui, H.Y., et al. (2019) Pyruvate Kinase M2 Contributes to Cell Growth in Gastric Cancer via Aerobic Glycolysis. Pathology, Research and Practice, 215, Article ID: 152409. https://doi.org/10.1016/j.prp.2019.04.001
|
[21]
|
翁映玲. 血清TuM2-PK、TK1、HER-2表达水平对直肠癌的诊断价值[J]. 河南医学研究, 2018, 27(10): 1795-1797.
|
[22]
|
樊晓静, 史志涛, 孙昕. TuM2-PK、TK1、CEA、CA19-9和CA72-4在结肠癌患者诊断中的意义[J]. 中国老年学杂志, 2019, 39(4): 814-816.
|
[23]
|
齐容容, 刘卫华, 常娅洁. 血清CEA和CA199及TuM2-PK水平联合检测对结肠癌诊断效能影响[J]. 社区医学杂志, 2021, 19(22): 1362-1365.
|
[24]
|
于同波, 刘程, 周珍娟. 血清CEA、CA125、CA199及血浆M2-PK联合检测胃癌的诊断价值研究[J]. 中国实用医药, 2018, 13(24): 3-5.
|
[25]
|
钟世洪, 成志烜, 王卓. 血清CEA CA199 CA125及血浆M2-PK联合检测在胃癌诊断中的临床研究[J]. 基层医学论坛, 2018, 22(1): 1-2.
|
[26]
|
Wang, C., Jiang, J., Ji, J., et al. (2017) PKM2 Promotes Cell Migration and Inhibits Autophagy by Mediating PI3K/ AKT Activation and Contributes to the Ma-lignant Development of Gastric Cancer. Scientific Reports, 7, Article No. 2886. https://doi.org/10.1038/s41598-017-03031-1
|
[27]
|
陈洈伟. 丙酮酸激酶M2蛋白与胃癌的临床病理联系[J]. 中国继续医学教育, 2020, 12(23): 102-104.
|
[28]
|
徐明静, 芦东徽, 高世乐, 等. 原发性肝癌组织中PKM2、COX2及IAPs的表达及其与放疗敏感性的关系分析[J]. 安徽医科大学学报, 2021, 56(10): 1612-1616.
|
[29]
|
马欢, 芦东徽, 徐滨, 等. 肝癌组织中PKM2表达及与放疗敏感性的关系[J]. 临床与实验病理学杂志, 2020, 36(2): 192-194.
|
[30]
|
徐强, 宋杰, 许敏, 等. M2型丙酮酸激酶同工酶表达对肝细胞癌化疗敏感性的影响[J].介入放射学杂志, 2019, 28(9): 855-860.
|
[31]
|
赵睿. M2型丙酮酸激酶(PKM2)与肝细胞癌恶性增生及预后相关的功能研究[D]: [博士学位论文]. 兰州: 兰州大学, 2019.
|
[32]
|
Bandara, I.A., Baltatzis, M., Sanyal, S., et al. (2018) Evaluation of Tu-mor M2-Pyruvate Kinase (Tumor M2-PK) as a Biomarker for Pancreatic Cancer. World Journal of Surgical Oncology, 16, 56.
https://doi.org/10.1186/s12957-018-1360-3
|
[33]
|
Goonetilleke, K.S., Mason, J.M., Siriwardana, P., et al. (2007) Diagnostic and Prognostic Value of Plasma Tumor M2 Pyruvate Kinase in Periampullary Cancer: Evidence for a Novel Biological Marker of Adverse Prognosis. Pancreas, 34, 318-324. https://doi.org/10.1097/MPA.0b013e31802ee9c7
|
[34]
|
王金, 赵一洁, 尚培中, 等. 胆管癌患者血清肿瘤型M2丙酮酸激酶水平变化及临床意义[J]. 中国普通外科杂志, 2020, 29(2): 220-227.
|
[35]
|
柴浩, 熊新魁, 孙道一, 等. PKM2基因对胆管细胞癌迁移、侵袭及增殖的影响[J]. 南京医科大学学报(自然科学版), 2015, 35(5): 615-621.
|
[36]
|
Li, Y.G. and Zhang, N. (2009) Clinical Significance of Serum Tumour M2-PK and CA19-9 Detection in the Diagnosis of Cholangiocarcinoma. Digestive and Liver Disease, 41, 605-608. https://doi.org/10.1016/j.dld.2008.11.010
|
[37]
|
张汗磊, 王松, 陈思, 等. 粪便肿瘤M2型丙酮酸激酶在结直肠癌和腺瘤性息肉中的诊断价值[J]. 医学信息, 2021, 34(12): 78-81.
|
[38]
|
Bond, A.D., Burkitt, M.D., Sawbridge, D., et al. (2016) Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenoma-tous Neoplasia in a Secondary Care Cohort. The Journal of Gastrointestinal and Liver Diseases, 25, 71-77. https://doi.org/10.15403/jgld.2014.1121.251.m2p
|